Nephros, Inc.
NEPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -0.5% | 42.7% | -2.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 61.6% | 59% | 47.4% | 55.1% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 1.6% | -9.5% | -37% | -24.4% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 0.5% | -11.1% | -74% | -40.2% |
| EPS Diluted | 0.007 | -0.15 | -0.72 | -0.41 |
| % Growth | 104.7% | 79.2% | -75.6% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |